Long-term outcomes after neoadjuvant trastuzumab and chemotherapy for HER2+ breast cancer.
A. Gropper
No relevant relationships to disclose
H. J. Burstein
No relevant relationships to disclose
L. Harris
No relevant relationships to disclose
K. S. Anderson
No relevant relationships to disclose
J. M. Gold
No relevant relationships to disclose
W. J. Younger
No relevant relationships to disclose
C. A. Bunnell
No relevant relationships to disclose
J. S. Najita
No relevant relationships to disclose
E. P. Winer
No relevant relationships to disclose
E. L. Mayer
No relevant relationships to disclose